Document is current
Any future updates will be listed below
-
Authors
Snyder, Daniel E. http://orcid.org/0000-0002-4091-6297
Wiseman, Scott
Crawley, Elizabeth
Wallace, Kim
Bowman, Dwight D.
Reinemeyer, Craig R.
- License Information
-
More Information
Article History
Received: 3 February 2021
Accepted: 3 May 2021
First Online: 17 May 2021
Declarations
:
: These laboratory dose confirmation studies were conducted in compliance with local and national regulatory requirements, including approval by the study site animal care and use committee, and were consistent with the principles of Good Clinical Practices (VICH guideline on good clinical practice [GCP; VICH GL9]), cited VICH referenced anthelmintic guidelines as well as cited and referenced World Association for the Advancement of Veterinary Parasitology (WAAVP) anthelmintic guidelines.
: Not applicable.
: These studies were funded by Elanco Animal Health. DES, SW, EC, and KW are current or former employees of Elanco Animal Health. DDB and CRR contracted as the study investigator and/or the contracted veterinary parasitologist for each laboratory study. The handling editors have been involved in consulting services (Filipe Dantas-Torres), research projects (Filipe Dantas-Torres, Adnan Hodžic) and meetings (Filipe Dantas-Torres) sponsored by different veterinary pharmaceutical companies in the past 10 years, including Elanco. They declare that each manuscript in this collection was handled impartially and peer reviewed rigorously by at least two independent external reviewers.
